°²öÎÓéÀÖ¹ÙÍø

°²öÎÓéÀÖ¹ÙÍøÑÛ¿Æ
Ä¿½ñλÖ㺠Ê×Ò³ > ¾ÍÕïÖ¸ÄÏ > ³£¼ûÑÛ²¡ÐÂÎÅ > ÕýÎÄ

¼±ÐÔÊÓÍøÄ¤»µËÀ(acute retinalnecrosis £¬ARN)Ò½ÖÎÑо¿

×÷ÕߣºÎ´Öª 2019-04-15 17:07:07
×ÖÌå´óС£º
¡¾µ¼¶Á¡¿¼±ÐÔÊÓÍøÄ¤»µËÀ(acute retinalnecrosis £¬ARN)Ò½ÖÎÑо¿

¡¡¡¡¼±ÐÔÊÓÍøÄ¤»µËÀ(acute retinalnecrosis £¬ARN)Ò½ÖÎÑо¿ £¬ARNÊÇÓÉÓÚ²¡¶¾Ñ¬È¾ÒýÆðÁËÊÓÍøÄ¤»µËÀÐÔ¸Ä±ä £¬²¡ÇéÉú³¤Ñ¸ËÙ £¬Ô¤ºó²î¡£²¡Ô­Î¢ÉúÎïÖ÷ҪΪˮ¶»-´ø×´ðåÕ¶¾(varicella zoster virus £¬VZV)¡¢´¿´âðåÕ¶¾(herpes simplex virus £¬HSV)1ÐÍ(HSV-1)ºÍHSV-2 £¬Å¼Óб¨µÀÆäÓɾÞϸ°û²¡¶¾(cytomegalovirus £¬CMV)[38]ºÍ EB(epstein-barr virus)²¡¶¾ÒýÆð¡£½ÓÄÉPCR¼ì²âHSV-1¡¢HSV-2ºÍVZVµÄDNA £¬»ò¼ì²âHSVºÍVZV¿¹ÌåµÄGWϵÊý £¬Òѱ»ÄÉÈë еÄARNÕï¶Ï±ê×¼¡£PCR¼ì²âHSV¡¢CMVºÍVZVµÄÌØÒì¶ÈºÍÃô¸Ð¶È¾ù¸ßÓÚ90%¡£

¡¡¡¡½üÆÚÃÀ¹úÑÛ¿ÆÐ­»áµÄÒ»ÏîÑо¿Ð§¹ûÏÔʾ £¬ÔÚÒÉËÆARN»¼ÕßÖÐ £¬79%¡«99%½ÓÄÉPCR¿É¼ì²â³ö·¿Ë®»ò²£Á§ÌåÒºÖб£´æHSV»òVZV¡£Tanaka-KitajimaµÈ½ÓÄÉPCRÔÚ3ËêARN»¼¶ùµÄÑÛ·¿Ë®Öмì²â³öHSV-2µÄDNA¡£AbeµÈÑо¿Ð§¹û֤ʵ £¬²»µ«½ÓÄÉPCR¼ì²âHSVºÍVZV²¡¶¾ºËËá¹ØÓÚÕï¶ÏARN¾ßÓÐÌØÒìÐÔ £¬¼ì²âHSVºÍVZV¿¹Ìå²¢ÅÌËãGWϵÊýҲͬÑù¾ßÓÐÌØÒìÐÔ¡£

¡¡¡¡Ó¡¶ÈÑо¿ÕßÉõÖÁ·¢Ã÷ £¬½ÓÄÉøÁªÃâÒßÎü¸½ÊÔÑé(enzyme-linkedimmunosorbent assay £¬ELISA)¼ì²âHSV ºÍVZV¿¹Ìå £¬¹ØÓÚARNÕï¶ÏµÄÃô¸Ð¶È¸ü¸ß¡£PCR¼ì²âHSVºÍVZVºËËáµÄÑôÐÔÂÊΪ6.7%ºÍ23.3% £¬¶øELISA¼ì²âHSVºÍVZV¿¹ÌåµÄÑôÐÔÂÊΪ43.3%ºÍ80.0%¡£¶ÔÑÛÄÚҺϸ°ûÒò×Ó¾ÙÐÐÑо¿ £¬Ð§¹ûÏÔʾÓë±ÈÕÕ×éÏà±È £¬IL-6¡¢IL-8¡¢IL-18¡¢¾ÞÊÉϸ°ûÒÆ¶¯ÒÖÖÆÒò×Ó¡¢µ¥ºËϸ°ûÇ÷»¯ÂѰ×1¡¢ÊÈËáÐÔÁ£Ï¸°û»î»¯Ç÷»¯Òò×Ó¡¢ÓÕµ¼ÂѰ×10¡¢IL-15¡¢¿ÉÈÜÐÔϸ°û¼ä𤸽·Ö×Ó1ºÍ¿ÉÈÜÐÔѪ¹Üϸ°û𤸽Òò×Ó1µÈ´ÙÑ×ÐÔ·´Ó¦Ï¸°ûÒò×ÓºÍѪ¹Üµ÷ÀíÒò×Ó £¬ÔÚARN»¼ÕßÑÛÄÚÒºÖÐŨ¶È¿É Éý¸ß £¬ÇÒÑ×ÐÔ·´Ó¦ÒÖÖÆÒò×ÓIL-10ÔÚARN»¼ÕßÑÛÄÚÒºÖеÄŨ¶ÈÒ²ÏÔ×ÅÉý¸ß¡£ÑÛÄÚÒºÒòËØ¼ì²âЧ¹û¿É²¿·ÖÌáÐÑARNµÄÔ¤ºó £¬ÈçÑÛÄÚÒºÖÐVEGFº¬Á¿ÓëÊÓÍøÄ¤²¡±ä¹æÄ£Ïà¹Ø(P<0.01) £¬ÓëÊÓÁ¦Ô¤ºó²îÏà¹Ø(P=0.031)¡£ÈôÊÇǰ·¿Ë®ÖÐVZV»òHSVµÄDNAÔØÁ¿Áè¼Ý5.0¡Á10 9 /L £¬ARN»¼ÕßµÄÊÓÁ¦Ô¤ºó¸ü²î £¬±¬·¢ÊÓÍøÄ¤ÍÑÀëµÄ¿ÉÄÜÐÔ¸ü¸ß¡£


ÔÚÏß×Éѯ
·µ»Ø
?
  • »ª±±µØÇø
  • »ªÄϵØÇø
  • Î÷ÄϵØÇø
  • »ªÖеØÇø
  • »ª¶«µØÇø
  • Î÷±±µØÇø
  • ¶«±±µØÇø
°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÎ¢ÐŹ«ÖںŠ΢ÐŹ«ÖÚºÅ
΢²©
ÍøÕ¾µØÍ¼